(DAUNORUBICIN AND CYTARABINE) LIPOSOME

2431 reported adverse events

Drug classes: Anthracycline Topoisomerase Inhibitor [EPC] Nucleoside Metabolic Inhibitor [EPC]

These side effects are most commonly reported by patients taking (DAUNORUBICIN AND CYTARABINE) LIPOSOME:

# Side effect Count
0 FEBRILE NEUTROPENIA 528
1 ACUTE MYELOID LEUKAEMIA 313
2 DEATH 244
3 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 217
4 PYREXIA 206
5 ACUTE MYELOID LEUKAEMIA RECURRENT 177
6 RASH 152
7 PNEUMONIA 151
8 SEPSIS 142
9 OFF LABEL USE 121
See all common reactions for (DAUNORUBICIN AND CYTARABINE) LIPOSOME

(DAUNORUBICIN AND CYTARABINE) LIPOSOME is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CYTARABINE SYNDROME 32 0.4211
1 CLOSTRIDIUM TEST 11 0.3548
2 CORYNEBACTERIUM BACTERAEMIA 11 0.1294
3 ACUTE MYELOID LEUKAEMIA REFRACTORY 15 0.0872
4 ACUTE MYELOID LEUKAEMIA RECURRENT 177 0.0824
5 SEPTAL PANNICULITIS 5 0.0625
6 CORYNEBACTERIUM SEPSIS 3 0.0455
7 BLAST CELLS PRESENT 20 0.0416
8 BLAST CELL COUNT INCREASED 41 0.0391
9 MYELOBLAST COUNT INCREASED 3 0.0390
See all enriched reactions for (DAUNORUBICIN AND CYTARABINE) LIPOSOME